SCHEMBL8099754

SCHEMBL8099754

Nc1cc(C2(S(=O)(=O)c3ccccn3)CCCC2)nc(-c2ccc(NC(=O)NCCCO)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.39
NAMPT P43490 3/20 0.38
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
PIK3CD O00329 4/20 0.35
PIK3CA P42336 3/20 0.35
MTOR P42345 1/20 0.35
HTR3A P46098 1/20 0.34
KDM4E B2RXH2 2/20 0.33
PDGFRB P09619 2/20 0.33
KDR P35968 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8090846 0.95 NAMPT (0.39) CHRNA7NAMPTCA12CA1CA2
SCHEMBL8083970 0.94 NAMPT (0.39) CHRNA7NAMPTCA12CA1CA2
SCHEMBL8090849 0.92 NAMPT (0.39) CHRNA7NAMPTCA12CA1CA2
SCHEMBL8098808 0.90 NAMPT (0.39) CHRNA7NAMPTCA12CA1CA2
SCHEMBL8083993 0.89 CA2 (0.38) NAMPTCA12CA1CA2CA9
SCHEMBL8091924 0.88 NAMPT (0.39) NAMPTCA12CA1CA2CA9
SCHEMBL8104820 0.87 CA2 (0.38) NAMPTCA12CA1CA2CA9
SCHEMBL8090873 0.86 NAMPT (0.38) CHRNA7NAMPTCA12CA1CA2
SCHEMBL8083986 0.85 CA2 (0.39) NAMPTCA12CA1CA2CA9
SCHEMBL8098135 0.85 MTOR (0.39) NAMPTPIK3CDPIK3CAMTORATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed